12 Health Care Stocks Moving In Monday's Pre-Market Session
I'm LongbridgeAI, I can summarize articles.In Monday's pre-market session, several healthcare stocks showed significant movement. Gainers included Advanced Biomed (+24.1%), Barinthus Biotherapeutics (+10.17%), HCW Biologics (+10.0%), Camp4 Therapeutics (+9.97%), Atara Biotherapeutics (+7.27%), and Genenta Science (+7.09%). Conversely, losers featured BioVie (-15.6%), GlucoTrack (-13.4%), Bluejay Diagnostics (-11.04%), Valion Bio (-10.94%), Elutia (-9.48%), and GRI Bio (-9.34%).
Gainers
- Advanced Biomed (NASDAQ:ADVB) shares rose 24.1% to $6.24 during Monday's pre-market session. The market value of their outstanding shares is at $8.2 million.
- Barinthus Biotherapeutics (NASDAQ:BRNS) shares rose 10.17% to $0.61. The market value of their outstanding shares is at $22.6 million.
- HCW Biologics (NASDAQ:HCWB) shares rose 10.0% to $4.4. The company's market cap stands at $6.3 million.
- Camp4 Therapeutics (NASDAQ:CAMP) stock rose 9.97% to $4.08. The market value of their outstanding shares is at $192.6 million.
- Atara Biotherapeutics (NASDAQ:ATRA) shares rose 7.27% to $9.0. The company's market cap stands at $75.5 million.
- Genenta Science (NASDAQ:GNTA) stock increased by 7.09% to $1.66. The market value of their outstanding shares is at $36.3 million.
Losers
- BioVie (NASDAQ:BIVI) shares decreased by 15.6% to $1.52 during Monday's pre-market session. The market value of their outstanding shares is at $13.5 million.
- GlucoTrack (NASDAQ:GCTK) shares declined by 13.4% to $0.43. The company's market cap stands at $3.2 million.
- Bluejay Diagnostics (NASDAQ:BJDX) stock decreased by 11.04% to $1.29. The company's market cap stands at $1.5 million.
- Valion Bio (NASDAQ:VBIO) shares decreased by 10.94% to $0.45. The market value of their outstanding shares is at $1.6 million.
- Elutia (NASDAQ:ELUT) shares fell 9.48% to $0.86. The market value of their outstanding shares is at $41.9 million.
- GRI Bio (NASDAQ:GRI) shares fell 9.34% to $1.36. The company's market cap stands at $2.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.